NCT05943080View on ClinicalTrials.gov

Comparison of IPACK Block and PCI for Postoperative Analgesia and Function Recovery Following Total Knee Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

August 10, 2023

Study Completion Date

December 15, 2023

Conditions
Total Knee ArthroplastyKnee Pain, Functionality
Interventions
DRUG

PCI (0.25% marcaine+ 2.0 μg/mL of adrenaline + %0.9 saline)

The application is made into the anatomical space between the posterior capsule and the popliteal artery before implantation.

DRUG

IPACK(0.25% marcaine+ 2.0 μg/mL of adrenaline + %0.9 saline)

It is applied to the anatomical space between the posterior capsule and the popliteal artery with the help of USG.

DRUG

ACB ( 0.25% marcaine + %0.9 saline)

It is inserted into the adductor canal by simultaneous imaging of the needle, accompanied by ultrasonography, from the level just below the sartorius muscle.

Trial Locations (1)

40100

Ahievran university, Kirşehi̇r

All Listed Sponsors
lead

Kirsehir Ahi Evran Universitesi

OTHER

NCT05943080 - Comparison of IPACK Block and PCI for Postoperative Analgesia and Function Recovery Following Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter